Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter F Buckley

Showing results (91-100 of 171) with videos related to

Pageof 18
Sort By:
Schizophrenia Bulletin|November 12, 2014
Meta-Analysis of Anti-Toxoplasma gondii IgM Antibodies in Acute PsychosisJoel M Monroe, Peter F Buckley, Brian J Miller
Brain Research. Cognitive Brain Research|July 5, 2005
Stimulus sequence affects schizophrenia-normal differences in event processing during an auditory oddball taskCasey S Gilmore, Brett A Clementz, Peter F Buckley
The Journal of Clinical Psychiatry|January 5, 2007
The art and science of switching of antipsychotic medications, part 1Peter J Weiden, Allan H Young, Peter F Buckley
Psychiatry (Edgmont (Pa. : Township))|September 4, 2009
Current Management of Schizophrenia: Antipsychotic Monotherapy versus Combination TherapyElisa F Cascade, Amir H Kalali, Peter F Buckley
Schizophrenia Research|August 28, 2017
Inflammation, substance use, psychopathology, and cognition in phase 1 of the clinical antipsychotic trials of intervention effectiveness studyBrian J Miller, Peter F Buckley, Joseph P McEvoy
Schizophrenia Research|July 24, 2014
Cysteamine, a pro-BDNF drug, as an adjunctive treatment for schizophreniaPeter F Buckley, Brian J Miller, Anilkumar Pillai, et al.
Schizophrenia Research|February 20, 2007
Brain derived neurotropic factor in first-episode psychosisPeter F Buckley, Anilkumar Pillai, Denise Evans, et al.
Disease Markers|October 30, 2013
Biomarkers in schizophrenia: a brief conceptual considerationCynthia S Weickert, Thomas W Weickert, Anil Pillai, et al.
Psychiatry Research|February 14, 2013
A psychometric study of recovery among Certified Peer SpecialistsAnthony O Ahmed, Denis Birgenheir, Peter F Buckley, et al.
Schizophrenia Research|May 15, 2007
The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidonePeter F Buckley, Philip D Harvey, Christopher R Bowie, et al.
Pageof 18

Showing results (91-100 of 171) with videos related to

Sort By:
Pageof 18
Schizophrenia Bulletin|November 12, 2014
Meta-Analysis of Anti-Toxoplasma gondii IgM Antibodies in Acute PsychosisJoel M Monroe, Peter F Buckley, Brian J Miller
Brain Research. Cognitive Brain Research|July 5, 2005
Stimulus sequence affects schizophrenia-normal differences in event processing during an auditory oddball taskCasey S Gilmore, Brett A Clementz, Peter F Buckley
The Journal of Clinical Psychiatry|January 5, 2007
The art and science of switching of antipsychotic medications, part 1Peter J Weiden, Allan H Young, Peter F Buckley
Psychiatry (Edgmont (Pa. : Township))|September 4, 2009
Current Management of Schizophrenia: Antipsychotic Monotherapy versus Combination TherapyElisa F Cascade, Amir H Kalali, Peter F Buckley
Schizophrenia Research|August 28, 2017
Inflammation, substance use, psychopathology, and cognition in phase 1 of the clinical antipsychotic trials of intervention effectiveness studyBrian J Miller, Peter F Buckley, Joseph P McEvoy
Schizophrenia Research|July 24, 2014
Cysteamine, a pro-BDNF drug, as an adjunctive treatment for schizophreniaPeter F Buckley, Brian J Miller, Anilkumar Pillai, et al.
Schizophrenia Research|February 20, 2007
Brain derived neurotropic factor in first-episode psychosisPeter F Buckley, Anilkumar Pillai, Denise Evans, et al.
Disease Markers|October 30, 2013
Biomarkers in schizophrenia: a brief conceptual considerationCynthia S Weickert, Thomas W Weickert, Anil Pillai, et al.
Psychiatry Research|February 14, 2013
A psychometric study of recovery among Certified Peer SpecialistsAnthony O Ahmed, Denis Birgenheir, Peter F Buckley, et al.
Schizophrenia Research|May 15, 2007
The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidonePeter F Buckley, Philip D Harvey, Christopher R Bowie, et al.
Pageof 18